1. Generation of an Fsp1 (fibroblast‐specific protein 1)‐Flpo transgenic mouse strain. Issue 5 (19th March 2020) Authors: Cardot‐Ruffino, Victoire; Chauvet, Véronique; Caligaris, Cassandre; Bertrand‐Chapel, Adrien; Chuvin, Nicolas; Pommier, Roxane M.; Valcourt, Ulrich; Vincent, David; Martel, Sylvie; Aires, Sophie; Kaniewski, Bastien; Dubus, Pierre; Cassier, Philippe; Sentis, Stéphanie; Bartholin, Laurent Journal: Genesis Issue: Volume 58:Issue 5(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy. Issue 9 (12th July 2022) Authors: Alcazer, Vincent; Bonaventura, Paola; Tonon, Laurie; Michel, Emilie; Mutez, Virginie; Fabres, Clémentine; Chuvin, Nicolas; Boulos, Rasha; Estornes, Yann; Maguer‐Satta, Véronique; Geistlich, Kevin; Viari, Alain; Metzeler, Klaus H.; Hiddemann, Wolfgang; Batch, Aarif M. N.; Herold, Tobias; Caux, Chr... Journal: American journal of hematology Issue: Volume 97:Issue 9(2022) Page Start: 1200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy. (August 2022) Authors: Mallet, Marion; Boulos, Rasha E.; Alcazer, Vincent; Bonaventura, Paola; Estornes, Yann; Chuvin, Nicolas; Depil, Stéphane Journal: European journal of cancer Issue: Volume 171(2022) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗